Isofol Medical AB (publ) (STO: ISOFOL)
2.900
-0.290 (-9.09%)
Aug 30, 2024, 5:29 PM CET
Isofol Medical AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 20.52 | 44.56 | 66.24 | 14.32 | 11.81 | 19.92 | Upgrade
|
Cash & Short-Term Investments | 20.52 | 44.56 | 66.24 | 14.32 | 11.81 | 19.92 | Upgrade
|
Cash Growth | -64.08% | -32.74% | 362.61% | 21.25% | -40.73% | 64.46% | Upgrade
|
Other Receivables | - | 0.96 | 0.2 | 0.79 | 0.37 | 0.25 | Upgrade
|
Receivables | 3.21 | 0.96 | 0.2 | 0.79 | 0.37 | 0.25 | Upgrade
|
Prepaid Expenses | - | 0.52 | 0.59 | 0.17 | 0.19 | 0.17 | Upgrade
|
Other Current Assets | - | - | - | - | 2.65 | - | Upgrade
|
Total Current Assets | 23.73 | 46.04 | 67.02 | 15.27 | 15.01 | 20.35 | Upgrade
|
Property, Plant & Equipment | 88.27 | 66.39 | 1.89 | - | - | - | Upgrade
|
Other Intangible Assets | 34.28 | 34.28 | 80.15 | 78.1 | 74.74 | 71.31 | Upgrade
|
Other Long-Term Assets | 5.38 | 5.38 | 1.58 | 1.58 | 1.58 | 1.62 | Upgrade
|
Total Assets | 151.66 | 152.09 | 150.64 | 94.95 | 91.33 | 93.28 | Upgrade
|
Accounts Payable | 13.7 | 4.61 | 2.85 | 0.31 | 1.04 | 0.33 | Upgrade
|
Accrued Expenses | - | 0.58 | 0.98 | 0.88 | 0.68 | 1.39 | Upgrade
|
Current Portion of Long-Term Debt | 5.06 | 4.96 | - | - | - | - | Upgrade
|
Other Current Liabilities | - | 0.5 | 0.61 | 0.16 | 0.08 | 0.09 | Upgrade
|
Total Current Liabilities | 18.76 | 10.65 | 4.44 | 1.34 | 1.81 | 1.81 | Upgrade
|
Long-Term Debt | 2.52 | 2.47 | 4.77 | 4.59 | 4.41 | 4.24 | Upgrade
|
Other Long-Term Liabilities | 4.38 | 4.38 | - | - | 0.23 | 0.23 | Upgrade
|
Total Liabilities | 25.65 | 17.49 | 9.21 | 5.93 | 6.44 | 6.27 | Upgrade
|
Common Stock | 126.01 | 29.68 | 29.68 | 21.76 | 20.31 | 20.31 | Upgrade
|
Additional Paid-In Capital | - | 207.76 | 207.33 | 155.24 | 146.67 | 144.34 | Upgrade
|
Retained Earnings | - | -102.84 | -95.57 | -87.98 | -82.41 | -77.65 | Upgrade
|
Comprensive Income & Other | - | - | - | - | 0.31 | - | Upgrade
|
Shareholders' Equity | 126.01 | 134.6 | 141.44 | 89.02 | 84.89 | 87 | Upgrade
|
Total Liabilities & Equity | 151.66 | 152.09 | 150.64 | 94.95 | 91.33 | 93.28 | Upgrade
|
Total Debt | 7.58 | 7.43 | 4.77 | 4.59 | 4.41 | 4.24 | Upgrade
|
Net Cash (Debt) | 12.94 | 37.13 | 61.47 | 9.73 | 7.4 | 15.68 | Upgrade
|
Net Cash Growth | -74.03% | -39.60% | 531.64% | 31.53% | -52.82% | 103.25% | Upgrade
|
Net Cash Per Share | 0.33 | 0.90 | 2.10 | 0.33 | 0.27 | 0.67 | Upgrade
|
Filing Date Shares Outstanding | 39.57 | 39.57 | 39.57 | 29.01 | 27.5 | 27.08 | Upgrade
|
Total Common Shares Outstanding | 39.57 | 39.57 | 39.57 | 29.01 | 27.5 | 27.08 | Upgrade
|
Working Capital | 4.97 | 35.39 | 62.59 | 13.93 | 13.21 | 18.55 | Upgrade
|
Book Value Per Share | 3.18 | 3.40 | 3.57 | 3.07 | 3.09 | 3.21 | Upgrade
|
Tangible Book Value | 91.73 | 100.31 | 61.29 | 10.92 | 10.15 | 15.7 | Upgrade
|
Tangible Book Value Per Share | 2.32 | 2.53 | 1.55 | 0.38 | 0.37 | 0.58 | Upgrade
|
Land | - | - | 1.89 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.